These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 6337354)

  • 1. Long-term treatment of menorrhagia with mefenamic acid.
    Fraser IS; McCarron G; Markham R; Robinson M; Smyth E
    Obstet Gynecol; 1983 Jan; 61(1):109-12. PubMed ID: 6337354
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of mefenamic acid in patients with a complaint of menorrhagia.
    Fraser IS; Pearse C; Shearman RP; Elliott PM; McIlveen J; Markham R
    Obstet Gynecol; 1981 Nov; 58(5):543-51. PubMed ID: 7029369
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of mefenamic acid and norethisterone on measured menstrual blood loss.
    Cameron IT; Haining R; Lumsden MA; Thomas VR; Smith SK
    Obstet Gynecol; 1990 Jul; 76(1):85-8. PubMed ID: 2359570
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Randomised comparative trial of the levonorgestrel intrauterine system and mefenamic acid for the treatment of idiopathic menorrhagia: a multiple analysis using total menstrual fluid loss, menstrual blood loss and pictorial blood loss assessment charts.
    Reid PC; Virtanen-Kari S
    BJOG; 2005 Aug; 112(8):1121-5. PubMed ID: 16045528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of primary dysmenorrhea and dysmenorrhea because of IUP with PG-synthetase inhibitors.
    Dreher E; von Fischer B
    Adv Prostaglandin Thromboxane Res; 1980; 8():1487-93. PubMed ID: 6769316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A double-blind placebo-controlled crossover study of mebeverine and mefenamic acid in the treatment of primary dysmenorrhoea.
    Langrick AF; Gunn AD; Livesey H; Whitehead AM
    Br J Clin Pract; 1989 Sep; 43(9):317-21. PubMed ID: 2620043
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Measured menstrual blood loss in women with menorrhagia associated with pelvic disease or coagulation disorder.
    Fraser IS; McCarron G; Markham R; Resta T; Watts A
    Obstet Gynecol; 1986 Nov; 68(5):630-3. PubMed ID: 3763074
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reduction by naproxen of excessive menstrual bleeding in women using intrauterine devices.
    Davies AJ; Anderson AB; Turnbull AC
    Obstet Gynecol; 1981 Jan; 57(1):74-8. PubMed ID: 7005780
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of menstrual migraine with prostaglandin synthesis inhibitor mefenamic acid: double-blind study with placebo.
    Al-Waili NS
    Eur J Med Res; 2000 Apr; 5(4):176-82. PubMed ID: 10799353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Double-blind comparison of ketoprofen and mefenamic acid in the treatment of primary dysmenorrhea.
    Hébert JG; Le Morvan P; Bourgouin J
    Clin Ther; 1986; 8(3):329-35. PubMed ID: 3521860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A comparative study of ethamsylate and mefenamic acid in dysfunctional uterine bleeding.
    Chamberlain G; Freeman R; Price F; Kennedy A; Green D; Eve L
    Br J Obstet Gynaecol; 1991 Jul; 98(7):707-11. PubMed ID: 1883797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trial of the efficacy of mefenamic acid in relief of menorrhagia and/or dysmenorrhoea.
    Vairojanavong K; Limchitti D; Sasivimolkul V
    J Med Assoc Thai; 1983 Feb; 66(2):99-105. PubMed ID: 6343540
    [No Abstract]   [Full Text] [Related]  

  • 13. Studies in menorrhagia: (a) mefenamic acid, (b) endometrial prostaglandin concentrations.
    Haynes PJ; Flint AP; Hodgson H; Anderson AB; Dray F; Turnbull AC
    Int J Gynaecol Obstet; 1980; 17(6):567-72. PubMed ID: 6106574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy of and tolerance to mefenamic acid in dysfunctional hypermenorrhea].
    Martińez Alcalá FO; Casanova Alvarez N; Manzanilla Sevilla R; Gonzaĺez Iñiguez R; Martińez Reyes P
    Prensa Med Mex; 1979; 44(11-12):295-8. PubMed ID: 122303
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of menorrhagia during menstruation: randomised controlled trial of ethamsylate, mefenamic acid, and tranexamic acid.
    Bonnar J; Sheppard BL
    BMJ; 1996 Sep; 313(7057):579-82. PubMed ID: 8806245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Control of menorrhagia by the cyclo-oxygenase inhibitors naproxen sodium and mefenamic acid.
    Hall P; Maclachlan N; Thorn N; Nudd MW; Taylor CG; Garrioch DB
    Br J Obstet Gynaecol; 1987 Jun; 94(6):554-8. PubMed ID: 3304401
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A double-blind comparison of a propionic acid derivative (ibuprofen) and a fenamate (mefenamic acid) in the treatment of dysmenorrhea.
    Roy S
    Obstet Gynecol; 1983 May; 61(5):628-32. PubMed ID: 6835617
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment by tranexamic acid in menorrhagia in women using intrauterine devices].
    Bengtsson LP; Weström L
    Lakartidningen; 1971 Aug; 68(33):3685-91. PubMed ID: 5129410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison between mefenamic acid and danazol in the treatment of established menorrhagia.
    Dockeray CJ; Sheppard BL; Bonnar J
    Br J Obstet Gynaecol; 1989 Jul; 96(7):840-4. PubMed ID: 2765430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of mefenamic acid on controlling irregular uterine bleeding in DMPA users.
    Tantiwattanakul P; Taneepanichskul S
    Contraception; 2004 Oct; 70(4):277-9. PubMed ID: 15451330
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.